Search Results

The Atrium Graduated Wall Flixene Graft is intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.

Atrium Graduated Wall Flixene Graft

This document is a 510(k) clearance letter from the FDA for a medical device (Atrium Graduated Wall Flixene Graft). It does not contain any information about acceptance criteria, device performance testing, or studies conducted to prove the device meets specific criteria.

The letter primarily:

• States that the device has been reviewed and determined to be substantially equivalent to legally marketed predicate devices.
• Outlines post-market requirements and regulations the manufacturer must adhere to.
• Provides contact information for various FDA offices.
• Includes an "Indications For Use" statement.

Therefore, I cannot provide the requested information, such as:

1. A table of acceptance criteria and reported device performance.
2. Sample sizes or data provenance for a test set.
3. Number or qualifications of experts for ground truth.
4. Adjudication method.
5. Results of a multi-reader multi-case (MRMC) comparative effectiveness study.
6. Results of a standalone algorithm performance study.
7. Type of ground truth used.
8. Sample size for the training set.
9. How ground truth for the training set was established.

This document is a regulatory approval, not a technical report detailing performance studies.

Ask a specific question about this device